ARTHROPLASTY
No difference in migration or wear between cemented low-profile cups and standard cups : A randomized radiostereographic study of 53 patients over 3 years
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(11):93 Acta Orthop. 2007 Aug;78(4):479-8460 patients with primary osteoarthritis awaiting total hip replacement, from ages 60-80 years, were randomized to either receive THR using a low-profile Lubinus Flanged Anti-Luxation Cup (FAL) or the Lubinus Standard Eccentric cup. The results at 3 years indicated that there no difference between the Lubinus FAL cup and the Lubinus Standard cup with respect to migration and wear.
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
はい = 1
不確実＝0.5
無関係 = 0
いいえ = 0
報告基準評価では、著者が出版物内で試験の方法論的特徴や試験特性を報告する際の透明性を評価します。評価は以下の5つのカテゴリーに分類されます。
3/4
Randomization
2/4
Outcome Measurements
4/4
Inclusion / Exclusion
4/4
Therapy Description
3/4
Statistics
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
Fragility Indexは、重要な所見の解釈を助けるツールで、結果の強さの尺度を提供します。Fragility Indexは、その所見が有意でなくなるために、二項対立の結果に追加する必要がある連続した事象の数を表します。数値が小さいほど弱い所見を表し、数値が大きいほど強い所見を表します。
なぜ今この研究が必要なのですか？
In total hip replacement procedures, a higher degree of containment within the bony acetabulum is achieved with low-profile acetabular components. Incidence of radioluency and wear may be reduced with the complete bony containment of cups. The low-profile design allows for greater range of free motion before femoral neck and cup impingement occurs. However, in contrast, the low-profile cups result in decreased containment of the prosthetic head within the cup therefore increasing the risk of instability or dislocation. It was reported that use of the SHP (low-profile) cup resulted in increased migration and wear, at the same time as the Lubinus Flanged Anti-Luxation Cup (FAL) was being introduced. This resulted in the need to compare this FAL low-profile cup to Standard cups, in order to examine the safety of the FAL cup and it's effects of migration and wear.
主な研究課題は何ですか？
How does the low-profile Lubinus Flanged Anti-Luxation Cup (FAL) compare to the Lubinous Standard Eccentric cup, in terms of the effects on migration and wear, in patients with primary osetoarthritis undergoing total hip replacement, measured at a 3 year follow up period?
重要な知見は？
- There was no difference in cup migration (MTPM values) between the two groups (p=0.7 at 1 year, p=0.8 at 3 years).
- There was no difference between groups in terms of wear (p=0.9 at 1 year, p=0.7 at 3 years).
- The clinical results (WOMAC, VAS rest, VAS activity) were excellent, with no significant differences between both groups (all p>0.05).
- 3 cups (2 FAL, 1 Standard) reported increased proximal migration that indicated an increased risk of early loosening.
- No correlation was observed between migration and wear.
最も覚えておくべきことは？
There was no significant difference between The Lubinus FAL cup and the Lubinus Standard cup, in terms of migration and wear, measured at 1 and 3 years following surgery. Clinical outcomes were equally favorable in both groups.
それが私の患者ケアにどのように影響するか？
In patients where a low-profile cup is acceptable and suitable, this study indicates that the FAL cup is safe and effective for patients undergoing total hip replacement. Further high-quality evidence with larger sample sizes is needed to evaluate the safety and efficacy of this novel implant.
免責事項
このページに記載されている内容は、情報提供のみを目的としたものであり、専門的な医療アドバイス、診断、治療の代わりとなるものではありません。治療が必要な場合は、必ず医師の診断を仰ぐか、最寄りの救急外来を受診してください。このページに記載されている内容に関して個人が表明した意見、信念、見解は、OrthoEvidenceの意見、信念、見解を反映するものではありません。
0の4 月間無料記事のロック解除
